Brown, Lisle/Cummings, Inc. Precigen, Inc. Call Options Transaction History
Brown, Lisle/Cummings, Inc.
- $329 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PGEN
# of Institutions
140Shares Held
145MCall Options Held
292KPut Options Held
53.8K-
Third Security, LLC83.5MShares$75.1 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD18.2MShares$16.4 Million1.57% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$9.22 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.76MShares$6.08 Million0.0% of portfolio
-
Iridian Asset Management LLC3.78MShares$3.4 Million0.8% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $187M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...